Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032 Meeting Abstract
| Authors: | Antonia, S. J.; Bendell, J. C.; Taylor, M. H.; Calvo, E.; Jaeger, D.; De Braud, F. G.; Ott, P. A.; Pietanza, M. C.; Horn, L.; Le, D. T.; Morse, M.; Lopez-Martin, J. A.; Ascierto, P. A.; Christensen, O.; Grosso, J.; Simon, J. S.; Lin, C. S.; Eder, J. P. |
| Abstract Title: | Phase I/II study of nivolumab with or without ipilimumab for treatment of recurrent small cell lung cancer (SCLC): CA209-032 |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901633 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.7503 |
| Notes: | Meeting Abstract: 7503 -- Source: Wos |
